Skip to main content

Table 3 General data of all 20 patients enrolled in this study

From: Long-term telemetric intracranial pressure monitoring for diagnosis and therapy optimisation of idiopathic intracranial hypertension

ID

Sex

Main Symptoms

Papilledema

Previous Treatment

Type of Follow Up

Distance between home and clinic in kilometres

1

F

Headache

No

Topiramat

Home-monitoring

21

2

F

Headache

No

None

Home-monitoring

29

3

F

Sight impairment

Yes

Acetazolamide, Topiramat, furosemide, weight loss

Home-Tele-monitoring

174

4

F

Headache, sight impairment, dizziness

No

Acetazolamide, LPs

Home-monitoring

45

5

M

Headache, sight impairment

Yes

Acetazolamide, LPs

Home-Tele-monitoring

559

6

F

Headache, sight impairment

Yes

Acetazolamide, LPs

Home-Tele-monitoring

45

7

F

Headache

No

Acetazolamide, Topiramat

Home-Tele-monitoring

586

8

F

Dizziness

No

VP Shunt Codman valves

Home-Tele-monitoring

137

9

M

Headache, sight impairment

Yes

LPs

Home-Tele-monitoring

45

10

F

Headache, sight impairment

No

Acetazolamide, LPs

Home-monitoring

109

11

F

Headaches

No

LPs

Home-monitoring

21

12

F

Headaches

No

None

Home-Tele-monitoring

58

13

F

Headache, sight impairment (Blind)

No

None

Home-Tele-monitoring

740

14

F

Headache,

No

VP Shunt ProGAV valve with Shunt-Assistant (20 cm H2O)

Home-Tele-monitoring

158

15

M

Headache, nausea, vomiting

Yes

None

Home-monitoring

42

16

M

Headache, sight impairment

Yes

LPs

Home-monitoring

5

17

F

Headaches

No

Sumatriptan, Topiramat

Home-Tele-monitoring

178

18

F

Headaches

No

VP Shunt

Home-Tele-monitoring

190

19

F

Headaches

Yes

None

Home-monitoring

42

20

F

Headaches

No

Acetazolamide, LPs

Home-Tele-monitoring

112